Allergy to mould allergens as a risk factor for bronchial asthma development in patients suffering from allergic rhinitis;Uczulenie na alergeny grzybów pleśniowych jako czynnik ryzyka wysta̧pienia astmy oskrzelowej u chorych z alergicznym nieżytem nosa

Polski Merkuriusz Lekarski

Volumn 14, Issue 83, 2003, Pages 388-392

  Bogacka, Ewa ^a   Nittner Marszalska, Marita ^a   Fal, Andrzej M ^a   Kuźniar, Jolanta ^a   Nikiel, Elzbieta ^b   Małolepszy, Józef ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Poradnia Alergologiczna dla Dzieci   (Poland)

Author keywords

Allergic rhinitis; Mould allergy

Indexed keywords

ALLERGEN;

ALLERGIC RHINITIS; ALLERGY; ALTERNARIA; ARTICLE; ASTHMA; CLADOSPORIUM; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MOULD; PERENNIAL RHINITIS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; VALIDATION PROCESS;

ADOLESCENT; ADULT; ASTHMA; CHILD; FEMALE; HUMANS; HYPERSENSITIVITY; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, PERENNIAL; RISK FACTORS; SPORES, FUNGAL;

EID: 0037596700     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. ARIA Workshop Report. J. Allergy Clin. Immunol., 2001, 108, 5.
2. D'Amato G. i wsp.: Evaluation of the prevalence of skin prick test positivity to Alternaria and Cladosporium in patients with suspected respiratory allergy. Allergy, 1997, 52, 711-716.
3. Asero R., Bottazzi G.: Hypersensitivity to molds in patients with nasal polyposis. J. Allergy Clin. Immunol., 2000, 105, 1, 186-188.
4. Call R.S. i wsp.: Investigating severe and fatal asthma. J. Allergy Clin. Immunol., 1994, 94, 6, 1065-1072.
5. Dales R.E. i wsp.: Influence of ambient fungal spores on emergency visits for asthma to a regional children's hospital. Am. J. Resp. Crit. Care Med., 2000, 162, 2087-2090.
6. Ezeamuzie C.I. i wsp.: Asthma in the desert: spectrum of the sensitizing aeroalergens. Allergy, 2000, 55, 157-162.
7. Gergen P.J., Turkeltaub P.C.: The association of individual allergen reactivity with respiratory disease in a national sample. Data from the second National health and Nutrition Examination Survey, (NHANES II). J. Allergy Clin. Immunol., 1992, 90, 579-588.
8. Global Strategy for Asthma Management and Prevention, NHLBI/WHO workshop report. NIH Publ. No 94, Bethesda, 1994.
9. Gupta R. i wsp.: Standardization of growth parameters and immunochemical characterisation of Culvularia lunata fungal extract. Allergy Clin. Immunol. inter., 1997, suppl 4, 148.
10. Halonen M. i wsp.: Alternaria as a major Allergen for asthma in children raised in a desert environment. Am. J. Resp. Crit. Care Med., 1997, 155, 1356-1361.
11. O'Hollaren M. i wsp.: Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N. Engl. J. Med., 1991, 324, 359-363.
12. Katz Y. i wsp.: Indoor survey of moulds and prevalence of mould allergy. Israel. Clin. Exp. Allergy, 1999, 29, 186-192.
13. Kauffman H.F. i wsp.: Protease-dependent activation of epithelial cells by fungal allergens leads to morphologic changes and cytokine production. J. Allergy Clin. Immunol., 2000, 105, 1185-1193.
14. Kauffman H.F.: Fungal allergy and immune defense. Syllabus: Aerobiological and Clinical aspects of allergenic moulds. EAACI, Rhodos. 1997.
15. Kawaguchi H. i wsp.: Fungus-specyfic IgE antibodies on patients with atopic dermatitis. Allergy Clin. Immunol. inter., 1997, suppl. 4, 159.
16. Koivikko A., Viander M., Lanner A.: Use of the extended Phadebas RAST panel in the diagnosis of mould allergy in asthmatic children. Allergy, 1991, 46, 85-91.
17. Kurup V. i wsp.: Particulate Aspergillus fumigatus antigens elicit a Th2 reponse reponse in BALB/c mice. J. Allergy Clin. Immunol., 1994, 93, 1013-1020.
18. Kuzniar J. i wsp.: Mould allergies as the cause of allergic rhinosinusitis and sinus inflammation in children. New Med., 1999, 3, 30-32.
19. Leher S.B. i wsp.: Prevalence of basidiomycete allegy in the USA and Europe and its relationship to allergic respiratory symptoms. Allergy, 1994, 49, 460-465.
20. Lipiec A. i wsp.: Alternaria sensitization in patients with allergic rhinitis. Allergy, 2002, 57, suppl. 73, 288.
21. Meyer J.E. i wsp.: Eotaxin controversially supports to eosinophilic infiltration in nasal polyposis due to Aspergillus infection. Allergy, 2002, 57, supp. 73, 126.
22. Namysłowski G. i wsp.: Rola grzybów niedoskonalych w etiopatogenezie calorocznego alergicznego nieżytu nosa. Otolaryngol. Pol., 1998, LII, 3, 277-280.
23. Neukirch C. i wsp.: Is sensitization to Alternaria a risk factor for severe asthma? A population based study. J. Allergy Clin. Immunol., 1999, 103, 707-711.
24. Niemeijer N., de Monchy J.G.R.: Age - dependency of sensitization to aero - allergens in asthmatics. Allergy, 1999, 47, 431-435.
25. Nolles G. i wsp.: Relevance of immunoglobulin E for fungi in atopic children. Clin. Exp. Allergy, 2001, 31, 1564-1570.
26. Ozanguc N. i wsp.: Allergen spectrum of allergic rhinitis and bronchial asthma in Turkey and relationship between the allergens and month of birth, blood grups, familial atopy history. Allergy Clin. Immunol. Inter., 1997, suppl. 4, 137.
27. Perzanowski M.S. i wsp.: Association of sensitization to Alternaria allergens with asthma among school-age children. J. Allergy Clin. Immunol., 1998, 101, 5, 626-632.
28. Sergeev A.Y. i wsp.: Chronic mucocutaneous candidiasis: immunologic profile and patterns of hypersensitivity to candida albicans. Allergy, 2002, 57, suppl. 73, 294.
29. Szantho A. i wsp.: Study of mould allergy in asthmatic children in Hungary. J. Invest. Allergol. Clin. Immunol., 1992, 2, 84-90.
30. Tariq S.M. i wsp.: Sensitization to Alternaria and Cladosporium by the age of 4 years. Clin. Exp. Allergy, 1996, 26, 794-798.
31. Verhoeff A.P., Burge H.A.: Health risk assesment of fungi in home environments. Ann. Allergy Asthma Immunol., 1997, 78, 544-556.
32. Westergren V.S.: Refractory rhinosinusitis: possibly fungal matter? Clin. Exp. Allergy, 2001, 31, 1806-1808.